Incorporating lag time to benefit into prevention decisions for older adults
about
Incorporating prognosis in the care of older adults with multimorbidity: description and evaluation of a novel curriculum.Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort studyTime to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.Medical characteristics of the oldest old: retrospective chart review of patients aged 85+ in an academic primary care centre.Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trialsAn Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular eventsInterpretation of cardiovascular outcome trials in type 2 diabetes needs a multiaxial approach.GPs' perspectives on secondary cardiovascular prevention in older age: a focus group study in the Netherlands.Control beliefs and risk for 4-year mortality in older adults: a prospective cohort studyDrug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.Hypertension and aging.Comparing Prognostic Tools for Cancer Screening: Considerations for Clinical Practice and Performance Assessment.Appropriateness of medications prescribed to elderly patients with advanced heart failure and limited life expectancy who died during hospitalization.Studying cancer treatment in the elderly patient population.Exploring the enablers and barriers to implementing the Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria in Australia: a qualitative study.Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening.Receipt of Cancer Screening Is a Predictor of Life ExpectancyOne-Year Mortality After Hip Fracture: Development and Validation of a Prognostic Index.Primary Care Practitioners' Views on Incorporating Long-term Prognosis in the Care of Older Adults.Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?Lag time to benefit for preventive therapies.Individualizing Prevention for Older Adults.Effect of a new longitudinal interprofessional geriatric medicine educational track on knowledge and attitude of medical students: a controlled cohort study.Older Adults' Preferences for When and How to Discuss Life Expectancy in Primary Care.Changes in Prescribing Symptomatic and Preventive Medications in the Last Year of Life in Older Nursing Home Residents.Prognosis communication with older patients with multimorbidity: Assessment after an educational intervention.Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review.Value judgment of health interventions from different perspectives: arguments and criteria.
P2860
Q27308894-E3D12B63-857F-4D6C-86F5-A3E914D00F13Q28652095-C4370F88-FC2D-4469-A471-693619FEE4DAQ31060724-611B8748-F061-4C2B-A2CD-A8415326B813Q33770841-1E20390F-4C62-4435-B632-74A4E9C13E61Q33812170-E52E455B-F474-4021-8749-D4F09076DEFEQ34472158-38E6BB09-ADFB-4728-80A9-60D780F0E8DBQ34548875-4F4D8F64-2A9A-4EEA-B3E6-E60A1FC2BBE4Q35181821-616BB62E-6468-45E7-9114-C82538FE93D7Q35736564-66E4359F-CE73-465B-9084-D0594ECE0C36Q35932559-77A08D28-03EB-4A76-99F2-2A9E6E9698B9Q36197338-BF8660DF-A927-4B4B-BB68-C723B6761252Q36246641-609682D0-067A-4573-BB08-07DDCA79B75FQ36572076-FEB05890-D032-4014-8D55-63C1A021E161Q36603768-AA745D66-7B51-488D-9CF9-06AEC117DA36Q36623143-B9C0F810-D1A7-4C11-87B4-2BDEC0AE673BQ36940678-43191348-1204-4EA0-80BF-B3E9AD0ACB01Q38211614-DCFBE530-5FE6-4A32-9AC4-055BBAD03AACQ38222468-5078F0D4-3645-46D9-A0F1-09BB50196E38Q38609516-6C16D2B9-1CC6-41EC-9F65-52C8F64727DDQ38668005-C42A4EC3-4E72-4668-835D-4415EE070719Q39641007-2FCA89A6-4664-4130-B475-087ECC038C52Q39687656-69F790BD-99EE-4A48-A704-FBAC46600063Q40365817-1478852B-224E-4561-8581-AE49192C37C7Q40700380-23FFCFFC-8A14-417A-8BF5-21D56E225DA5Q42586727-93BF284D-6576-4BD5-B8C6-CEFDC297929BQ46122328-1FE06481-841E-4A27-8756-1F66A23CD0E2Q46979228-66B31201-CE05-4BAA-B55B-1EA83609C399Q47133580-9C59551E-3090-44FD-AA20-82494BC22341Q49777757-8F157E33-230A-41D1-81FA-121B8EF6B7A2Q50316928-7095392E-928C-48D8-9E9B-9117A2F9ABBEQ51800071-B77DC3C5-FA58-4C7D-9C7A-F5B885876067Q55007178-79F6FDD1-229F-42BE-9C6D-30FD6DBD2CB9
P2860
Incorporating lag time to benefit into prevention decisions for older adults
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Incorporating lag time to benefit into prevention decisions for older adults
@ast
Incorporating lag time to benefit into prevention decisions for older adults
@en
type
label
Incorporating lag time to benefit into prevention decisions for older adults
@ast
Incorporating lag time to benefit into prevention decisions for older adults
@en
prefLabel
Incorporating lag time to benefit into prevention decisions for older adults
@ast
Incorporating lag time to benefit into prevention decisions for older adults
@en
P2093
P2860
P356
P1476
Incorporating lag time to benefit into prevention decisions for older adults
@en
P2093
Louise C Walter
Rosanne M Leipzig
P2860
P304
P356
10.1001/JAMA.2013.282612
P407
P577
2013-12-01T00:00:00Z